Cargando…

Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence

Inflammatory markers have a wide range of predictive values in the prognosis of non-small lung cancer (NSCLC). Poor nutritional status usually means a poor prognosis in patients with NSCLC, which is widely recognized by oncologists and nutritionists. Serum albumin has a certain value in evaluating t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chuan-long, Gao, Meng-qi, Jiang, Xiao-chen, Pan, Xue, Zhang, Xi-yuan, Li, Yi, Shen, Qian, Chen, Yan, Pang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088931/ https://www.ncbi.nlm.nih.gov/pubmed/37036321 http://dx.doi.org/10.1080/07853890.2023.2192047

Ejemplares similares

Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR
por: Zhang, Chuan-long, et al.
Publicado: (2023)

Prognostic Values of Preoperative Inflammatory and Nutritional Markers for Colorectal Cancer
por: Zhang, Nannan, et al.
Publicado: (2020)

Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma
por: Zhang, Tiantian, et al.
Publicado: (2023)

ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma
por: Zhang, Yu, et al.
Publicado: (2022)

The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis
por: Li, Baibei, et al.
Publicado: (2022)

Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study
por: Wang, Yixi, et al.
Publicado: (2019)

The relationship between inflammatory response markers and the prognosis of non-muscle invasive bladder cancer and the development of a nomogram model
por: Yi, Xinping, et al.
Publicado: (2023)

Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma
por: Chen, Xiao-Yong, et al.
Publicado: (2022)

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
por: Kang, Jin, et al.
Publicado: (2020)

Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Chuan-Long, et al.
Publicado: (2022)

The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
por: Chen, Haiqing, et al.
Publicado: (2021)

Camrelizumab Combined With Gemcitabine and Albumin-Bound Paclitaxel for Neoadjuvant Therapy in the Treatment of Progressive Gallbladder Cancer: A Case Report
por: Wu, Jing, et al.
Publicado: (2022)

Evaluation and Validation of the Prognostic Value of Serum Albumin to Globulin Ratio in Patients With Cancer Cachexia: Results From a Large Multicenter Collaboration
por: Xie, Hai-Lun, et al.
Publicado: (2021)

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

Clinical Value of the Lactate/Albumin Ratio and Lactate/Albumin Ratio × Age Score in the Assessment of Prognosis in Patients With Sepsis
por: Chen, Xiaonan, et al.
Publicado: (2021)

Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer
por: Qiu, Zhaoyan, et al.
Publicado: (2020)

Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors
por: Zhang, Longshan, et al.
Publicado: (2020)

Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy
por: Han, Yifan, et al.
Publicado: (2022)

Association between radiotherapy and prognosis in patients with small cell carcinoma of the bladder undergoing bladder-sparing surgery
por: Liang, Fuchao, et al.
Publicado: (2023)

Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma
por: Zhang, Xue-wen, et al.
Publicado: (2020)

The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy
por: Zheng, Hua-chuan, et al.
Publicado: (2020)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

Prognostic Value of Postoperative Neutrophil and Albumin: Reassessment One Month After Gastric Cancer Surgery
por: Guner, Ali, et al.
Publicado: (2021)

Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020)

Prognostic Value of Platelet-Albumin-Bilirubin Grade in Child-Pugh A and B Patients With Hepatocellular Carcinoma: A Meta-Analysis
por: Liu, Rongqiang, et al.
Publicado: (2022)

The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer
por: Luo, Kai, et al.
Publicado: (2022)

Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer
por: Xiao, Zilong, et al.
Publicado: (2023)

C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
por: Martin, Daniel, et al.
Publicado: (2019)

An Adaptive Transfer-Learning-Based Deep Cox Neural Network for Hepatocellular Carcinoma Prognosis Prediction
por: Chai, Hua, et al.
Publicado: (2021)

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma
por: Peng, Wenguang, et al.
Publicado: (2023)

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
por: Zhang, Yanwei, et al.
Publicado: (2020)

The predictive value of the preoperative fibrinogen-albumin ratio on the postoperative prognosis of renal cell carcinoma
por: Liu, Jun, et al.
Publicado: (2020)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

The Evolving Role of (18)F-FDG PET/CT in Diagnosis and Prognosis Prediction in Progressive Prostate Cancer
por: Shen, Kai, et al.
Publicado: (2021)

Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment
por: Da, Liangshan, et al.
Publicado: (2023)

Progression Patterns, Treatment, and Prognosis Beyond Resistance of Responders to Immunotherapy in Advanced Non-Small Cell Lung Cancer
por: Xu, Yanjun, et al.
Publicado: (2021)

LncRNA FOXD3-AS1 Promotes the Malignant Progression of Nasopharyngeal Carcinoma Through Enhancing the Transcription of YBX1 by H3K27Ac Modification
por: Yang, Huiyun, et al.
Publicado: (2021)

Low Pretreatment Albumin-to-Globulin Ratio Predicts Poor Prognosis in Gastric Cancer: Insight From a Meta-Analysis
por: Wei, Chengzhi, et al.
Publicado: (2021)

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Weikang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6rgmdt5dhkl2crv0kds8evctv0